Scientists have uncovered a new way embryonic cells divide when conventional mechanisms fail. Cell division underpins all ...

Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss next steps NORTH ...

This article was reviewed by Sara Harcharik Perkins, MD. Key Takeaways: Folic acid (vitamin B9) supports healthy cell growth ...

Experts say hair loss treatments such as Rogaine and Propecia are effective and widely available. However, various treatments ...

GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative ...

GTB-5550 represents GT Biopharma's third NK cell engager advancing toward clinical development, targeting B7-H3, a protein prevalent across breast, lung, ovarian, pancreatic, prostate, bladder, and ...

GT Biopharma submitted an IND application for GTB-5550 TriKE for solid tumors. Phase 1 trial planned for 2026.

Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s ...

GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE(R) natural killer (NK ...

Plug-in hybrids can theoretically serve as stepping stones to all-electric vehicles, providing enough electric range for ...

Hoping for a glimpse of the Milky Way? These user-friendly apps help stargazers learn more about objects in the sky, check ...